Promega PBMC ADCC Bioassay combines physiologically representative primary cells with reliable quantitative readout technology Madison, WI USA. Drug developers have a new bioluminescent tool to characterize how potential pharmaceuticals behave in biologically relevant systems. A new primary cell bioassay from Promega Corporation uses peripheral blood mononuclear cells (PBMCs) to measure the antibody-dependent cellular cytotoxicity (ADCC) […]
Dr. David Ledbetter, Dr. Neil Martin and Chris Mattmann bring deep experience in healthcare and artificial intelligence to help Seven Bridges use biomedical data to improve health outcomes BOSTON – Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced the formation of its strategic advisory board tasked with advising Seven Bridges leadership team in its mission […]
An experienced leader in corporate development and operations steps into new role at growing start-up SAN DIEGO- November 20, 2020- Omniome, Inc., developer of an innovative DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, announces the promotion of Kelly Perez to Chief Operating Officer. Kelly, who has been Senior Vice President, Finance & Operations […]
Strategic collaboration combines germline genetic testing, next-generation tumor sequencing and world-class testing capabilities to elevate global precision oncology care SALT LAKE CITY — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a new strategic precision oncology collaboration with Intermountain Precision Genomics, a service of Intermountain Healthcare. This collaboration […]
FARMINGDALE, NEW YORK – EpigenTek, a Farmingdale, NY-based biotech firm specializing in epigenetic research products, has successfully developed and generated a new antibody: Furin Site Blocking Polyclonal Antibody (fbAB), that specifically targets the SARS-CoV-2-specific furin motif. This antibody has high sensitivity and specificity for the furin cleavage site of SARS-CoV-2 spike protein, and was shown in […]
Mobile platform intended to produce >1,000s of ready-to-use doses at the site of need in under 3 days Project leverages GE’s expertise regarding synthetic method for producing industrial amounts of DNA GE’s DNA-based approach could be compatible with new, recently approved RNA-based COVID-19 vaccines NISKAYUNA, NY – March 2, 2021 – Aiming to enable vaccine production […]
Highlights: Resolution Bioscience is a fast-growing, innovative leader in next-generation sequencing (NGS)-based oncology solutions. Combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with Agilent’s leadership in tissue-based companion diagnostics and global commercial and regulatory scale. Furthers Agilent’s participation in fast-growing NGS technologies for precision oncology, expanding Agilent’s addressable market by […]
Funding will advance 3D lung cell culture models to accelerate drug discovery Cambridge, UK: CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip, today announced it has received a grant from Innovate UK, the UK’s innovation agency, to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection. The funding […]
Astronomy and Pathology (AstroPath™) come together for the first time to discover and clinically validate new spatial phenotypic signatures using multiplex immunofluorescence. Marlborough, MA — Akoya Biosciences, Inc., The Spatial Biology Company®, today announced a collaboration with the Bloomberg-Kimmel Institute for Cancer Immunotherapy (BKI) and the Bloomberg Center for Physics and Astronomy at the Johns […]
SOUTH SAN FRANCISCO, Calif. & BOULDER, Colo. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Watchmaker Genomics today announced a broad partnership to enable innovative research across a wide range of high throughput sequencing applications including oncology and tumor […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
